Citations 2

Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity

JAMA Ophthalmology | April 23, 2020 | Volume: 138 | Issue: 6 | Pages: 698

10.1001/jamaophthalmol.2020.0334 | PMID 32324197

Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity

JAMA Ophthalmology | April 27, 2017 | Volume: 135 | Issue: 6 | Pages: 654

10.1001/jamaophthalmol.2017.1055 | PMID 28448664